7/106 sources · 6 publishersUpdated Oct 8, 22:28 UTC
Clarivate finalizes $600 million divestiture to Altaris
Clarivate completed the sale of its Life Sciences & Healthcare business to Altaris on October 6, 2026, for $600 million. The company will concentrate on its Academia & Government and Intellectual Property operations after the disposal. Clarivate plans to revise its full-year 2026 outlook when it releases third-quarter results on November 3, 2026.
Why it matters
Clarivate says it intends to direct the sale proceeds toward debt reduction and a stronger balance sheet. The updated full-year 2026 guidance will show the financial effect of removing the divested business.
Key facts
- 1Clarivate completed the disposal of its Life Sciences & Healthcare business to Altaris on October 6, 2026. prnewswire.com
- 2The deal value was $600 million and had been announced on July 6, 2026. prnewswire.com
- 3Clarivate's remaining operating segments are Academia & Government and Intellectual Property. sec.gov
- 4Clarivate is scheduled to issue third-quarter 2026 results on November 3, 2026 and revise full-year 2026 guidance for the disposal. prnewswire.com
Open questions
- Material 1 says sale proceeds were not disclosed, while materials 2 through 6 report a $600 million transaction value.
Summary written by AlphAI from 6 of 6 sources. Not investment advice. Figures are as stated by the linked sources.